7192 Federal Register / Vol. 87, No. 26 / Tuesday, February 8, 2022 / Notices 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 

21 CFR section; activity Form FDA No. Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average burden per 

response Total hours 

Amendment to an existing notification (170.101), 

amendment to a Pre-notification Consultation, or 

amendment to a Master File (concerning a food 

contact substance) 9.

3480A 80 1 80 0.5 (30 minutes) ......... 40 

171.1; Indirect Food Additive Petitions ........................ N/A 1 1 1 10,995 ......................... 10,995 

Use of Recycled Plastics in Food Packaging: Chemistry Considerations.N/A 65 1 65 25 ................................ 1,625 

Preparation of Food Contact Notifications for Food 

Contact Substances in Contact with Infant Formula 

and/or Human Milk.

........................ 2 1 2 5 .................................. 10 

Total ...................................................................... ........................ ........................ ........................ ........................ ..................................... 32,675 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

2 Notifications for food contact substance formulations and food contact articles. These notifications require the submission of Form FDA 3479 (‘‘Notification for a 

Food Contact Substance Formulation’’) only. 3 Duplicate notifications for uses of food contact substances. 

4 Notifications for uses that are the subject of exemptions under 21 CFR 170.39 and very simple food additive petitions. 

5 Notifications for uses that are the subject of moderately complex food additive petitions. 

6 Notifications for uses that are the subject of very complex food additive petitions. 

7These notifications require the submission of Form FDA 3480. 

8These notifications recommend the submission of Form FDA 3480. 

9These notifications recommend the submission of Form FDA 3480A. 

Based on a review of the information 

collection since our last request for 

OMB approval, we made adjustments to 

our burden estimate. The estimates are 

based on our current experience with 

the Food Contact Substance Notification 

Program and informal communication 

with industry. 

Our estimated burden for the 

information collection reflects an 

overall increase of 1,345 hours and a 

corresponding decrease of 5 responses. 

We attribute this adjustment to a 

decrease in Pre-Notification 

Consultations or Master Files by 40 

responses, a subsequent decrease of 

amendments to Pre-Notification 

Consultations or Master Files by 20 

responses, and an increase of 55 

respondents using the recommendations 

in the guidance document entitled ‘‘Use 

of Recycled Plastics in Food Packaging: 

Chemistry Considerations.’’ As the 

average burden for preparing recycling 

submissions is higher than for Prenotification Consultations or Master 

Files, this results in an overall increase 

in total burden even with an overall 

decrease in responses. 

Dated: February 2, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–02620 Filed 2–7–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the National Advisory 

Council on the National Health Service 

Corps 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the National 

Advisory Council on the National 

Health Service Corps (NACNHSC) will 

hold public meetings for the 2022 

calendar year (CY). Information about 

NACNHSC, agendas, and materials for 

these meetings can be found on the 

NACNHSC website at: https://

www.hrsa.gov/advisory-committees/ 

national-health-service-corps. 

DATES: NACNHSC meetings will be held 

on: 

• March 29, 2022, 9:00 a.m.–5:00 p.m. 

Eastern Time (ET) and March 30, 2022, 

9:00 a.m.–2:00 p.m. ET; 

• June 28, 2022, 9:00 a.m.–5:00 p.m. 

ET and June 29, 2022, 9:00 a.m.–2:00 

p.m. ET; and 

• November 15, 2022, 9:00 a.m.–5:00 

p.m. ET and November 16, 2022, 9:00 

a.m.–2:00 p.m. ET. 

ADDRESSES: Meetings may be held inperson, by teleconference, and/or 

ZOOM. For updates on how meetings 

will be held, visit the NACNHSC 

website 30 business days before the date 

of the meeting, where instructions for 

joining meetings either in-person or 

remotely will be posted. In-person 

NACNHSC meetings will be held at 

5600 Fishers Lane, Rockville, Maryland 

20857. For meeting information 

updates, go to the meetings page on the 

NACNHSC website at https://

www.hrsa.gov/advisory-committees/ 

national-health-service-corps/meetings. 

FOR FURTHER INFORMATION CONTACT: 

Diane Fabiyi-King, Designated Federal 

Official, Division of National Health 

Service Corps, HRSA, 5600 Fishers 

Lane, Rockville, Maryland 20857; phone 

(301) 443–3609; or 

NHSCAdvisoryCouncil@hrsa.gov. 

SUPPLEMENTARY INFORMATION: The 

NACNHSC consults with, advises, and 

makes recommendations to the 

Secretary of Health and Human Services 

with respect to the Secretary’s 

responsibilities in carrying out Subpart 

II, Part D of Title III of the Public Health 

Service Act (42 U.S.C. 254d–254k), as 

amended, including the designation of 

areas of the United States with health 

professional shortages and assignment 

of National Health Service Corps 

(NHSC) clinicians to improve the 

delivery of health services in health 

professional shortage areas. Since 

priorities dictate meeting times, be 

advised that start times, end times, and 

agenda items are subject to change. 

Refer to the meeting website listed 

above for any meeting updates. 

For CY 2022 meetings, agenda items 

may include, but are not limited to, the 

identification of NHSC priorities for 

future program issues and concerns; 

proposed policy changes by using the 

varying levels of expertise represented 

on the NACNHSC to advise on specific 

program areas; updates from clinician 

workforce experts; and education and 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 26 / Tuesday, February 8, 2022 / Notices 7193 

practice improvement in the training 

development of primary care clinicians. 

More general items may include: 

Presentations and discussions on the 

current and emerging needs of the 

health workforce; public health 

priorities; health care access and 

evaluation; NHSC-approved sites; HRSA 

priorities and other federal health 

workforce and education programs that 

impact the NHSC. 

Refer to the NACNHSC website listed 

above for all current and updated 

information concerning the CY 2022 

NACNHSC meetings, including draft 

agendas and meeting materials that will 

be posted 30 calendar days before the 

meeting. 

Members of the public will have the 

opportunity to provide comments. 

Public participants may submit written 

statements in advance of the scheduled 

meeting(s). Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Requests to submit a written statement 

or make oral comments to the 

NACNHSC should be sent to Diane 

Fabiyi-King using the contact 

information above at least 5 business 

days before the meeting date(s). 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Diane 

Fabiyi-King using the contact 

information listed above at least 10 

business days before the meeting(s) they 

wish to attend. If in-person meetings are 

held, they will occur in a federal 

government building and attendees 

must go through a security check to 

enter the building. All in-person 

attendees must follow the workplace 

safety protocols regarding COVID–19. 

Guidance is provided on the website 

https://www.saferfederalworkforce.gov/. 

Non-U.S. citizen attendees must notify 

HRSA of their planned attendance at an 

in-person meeting at least 20 business 

days prior to the meeting in order to 

facilitate their entry into the building. 

All attendees are required to present 

government-issued identification prior 

to entry. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–02606 Filed 2–7–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Mechanisms of Memory and Sound 

Processing. 

Date: March 11, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sepandarmaz Aschrafi, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040D, 

Bethesda, MD 20892, (301) 451.4251, 

Armaz.aschrafi@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: HIV/AIDS Biological. 

Date: March 14, 2022. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shahrooz Vahedi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 810G, 

Bethesda, MD 20892, (301) 496–9322, 

vahedis@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Chemistry, Biochemistry and 

Biophysics B. 

Date: March 15–16, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ian Frederick Thorpe, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 480–8662, ian.thorpe@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; BRAIN 

Initiative: Targeted BRAIN Circuits Projects. 

Date: March 16–17, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kirk Thompson, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1242, kgt@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Drug Development and 

Therapeutics (CDDT). 

Date: March 17–18, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Innate 

Immunity and Inflammatory Responses. 

Date: March 17, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liying Guo, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4198, 

MSC 7812, Bethesda, MD 20892, (301) 827– 

7728, lguo@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Digestive 

Sciences Small Business Activities. 

Date: March 17, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Santanu Banerjee, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2106, 

Bethesda, MD 20892, (301) 435–5947, 

banerjees5@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Bacterial Pathogenesis. 

Date: March 17–18, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 


khammond on DSKJM1Z7X2PROD with NOTICES